CRVO
Price
$6.05
Change
-$1.06 (-14.91%)
Updated
Jun 27 closing price
Capitalization
54.13M
ONC
Price
$241.23
Change
-$13.26 (-5.21%)
Updated
Jun 27 closing price
Capitalization
28.04B
54 days until earnings call
Interact to see
Advertisement

CRVO vs ONC

Header iconCRVO vs ONC Comparison
Open Charts CRVO vs ONCBanner chart's image
CervoMed
Price$6.05
Change-$1.06 (-14.91%)
Volume$739.7K
Capitalization54.13M
BeOne Medicines
Price$241.23
Change-$13.26 (-5.21%)
Volume$400.83K
Capitalization28.04B
CRVO vs ONC Comparison Chart in %
Loading...
CRVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRVO vs. ONC commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRVO is a Hold and ONC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (CRVO: $6.05 vs. ONC: $241.23)
Brand notoriety: CRVO and ONC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRVO: 331% vs. ONC: 115%
Market capitalization -- CRVO: $54.13M vs. ONC: $28.04B
CRVO [@Biotechnology] is valued at $54.13M. ONC’s [@Biotechnology] market capitalization is $28.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRVO’s FA Score shows that 0 FA rating(s) are green whileONC’s FA Score has 0 green FA rating(s).

  • CRVO’s FA Score: 0 green, 5 red.
  • ONC’s FA Score: 0 green, 5 red.
According to our system of comparison, CRVO is a better buy in the long-term than ONC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRVO’s TA Score shows that 4 TA indicator(s) are bullish while ONC’s TA Score has 4 bullish TA indicator(s).

  • CRVO’s TA Score: 4 bullish, 2 bearish.
  • ONC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CRVO is a better buy in the short-term than ONC.

Price Growth

CRVO (@Biotechnology) experienced а -11.68% price change this week, while ONC (@Biotechnology) price change was -2.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ONC is expected to report earnings on Aug 22, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ONC($28B) has a higher market cap than CRVO($54.1M). CRVO YTD gains are higher at: 158.547 vs. ONC (30.599). CRVO has higher annual earnings (EBITDA): -20.94M vs. ONC (-116.48M). ONC has more cash in the bank: 2.52B vs. CRVO (35.2M). CRVO has less debt than ONC: CRVO (0) vs ONC (997M). ONC has higher revenues than CRVO: ONC (4.18B) vs CRVO (0).
CRVOONCCRVO / ONC
Capitalization54.1M28B0%
EBITDA-20.94M-116.48M18%
Gain YTD158.54730.599518%
P/E Ratio4.73N/A-
Revenue04.18B-
Total Cash35.2M2.52B1%
Total Debt0997M-
FUNDAMENTALS RATINGS
CRVO vs ONC: Fundamental Ratings
CRVO
ONC
OUTLOOK RATING
1..100
5563
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
58
Fair valued
PROFIT vs RISK RATING
1..100
10077
SMR RATING
1..100
9893
PRICE GROWTH RATING
1..100
5845
P/E GROWTH RATING
1..100
66100
SEASONALITY SCORE
1..100
n/a36

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRVO's Valuation (39) in the Biotechnology industry is in the same range as ONC (58). This means that CRVO’s stock grew similarly to ONC’s over the last 12 months.

ONC's Profit vs Risk Rating (77) in the Biotechnology industry is in the same range as CRVO (100). This means that ONC’s stock grew similarly to CRVO’s over the last 12 months.

ONC's SMR Rating (93) in the Biotechnology industry is in the same range as CRVO (98). This means that ONC’s stock grew similarly to CRVO’s over the last 12 months.

ONC's Price Growth Rating (45) in the Biotechnology industry is in the same range as CRVO (58). This means that ONC’s stock grew similarly to CRVO’s over the last 12 months.

CRVO's P/E Growth Rating (66) in the Biotechnology industry is somewhat better than the same rating for ONC (100). This means that CRVO’s stock grew somewhat faster than ONC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRVOONC
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
77%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
73%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 3 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CRVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HEFA38.210.47
+1.25%
iShares Currency Hedged MSCI EAFE ETF
SPXV67.400.37
+0.54%
ProShares S&P 500® ex-Health Care
FTHY14.840.05
+0.34%
First Trust High Yield Opportunities 2027 Term Fund
HKND32.330.10
+0.30%
Humankind US Stock ETF
RFIX47.55-1.29
-2.64%
Simplify Downside Interest Rate Hedge Strategy ETF

CRVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVO has been loosely correlated with TCRX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CRVO jumps, then TCRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVO
1D Price
Change %
CRVO100%
-14.85%
TCRX - CRVO
36%
Loosely correlated
-5.41%
LVTX - CRVO
28%
Poorly correlated
+0.77%
ADCT - CRVO
24%
Poorly correlated
+0.37%
TRDA - CRVO
24%
Poorly correlated
-1.57%
ONC - CRVO
24%
Poorly correlated
-5.21%
More

ONC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONC has been loosely correlated with ZLAB. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ONC jumps, then ZLAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONC
1D Price
Change %
ONC100%
-5.21%
ZLAB - ONC
55%
Loosely correlated
-3.87%
TCRX - ONC
34%
Loosely correlated
-5.41%
RGNX - ONC
33%
Poorly correlated
-4.11%
IPSC - ONC
31%
Poorly correlated
-5.74%
AUTL - ONC
31%
Poorly correlated
N/A
More